Protein-based photothermal theranostics for imaging-guided cancer therapy-Reference-Cited by-同舟云学术

Protein-based photothermal theranostics for imaging-guided cancer therapy

Published:2015 Issue:39 Volume:7 Page:16330-16336
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Rong Pengfei¹²³⁴⁵,Huang Peng⁵⁶⁷⁸⁹,Liu Zhiguo¹⁰³⁴,Lin Jing¹¹⁶⁷⁸,Jin Albert¹¹⁶⁷⁸,Ma Ying⁵⁶⁷⁸,Niu Gang⁵⁶⁷⁸,Yu Lun¹⁰³⁴,Zeng Wenbin¹⁰³⁴,Wang Wei¹²³⁴,Chen Xiaoyuan⁵⁶⁷⁸

Affiliation:

1. Department of Radiology

2. the Third Xiangya Hospital

3. Central South University

4. Changsha, PR China

5. Laboratory of Molecular Imaging and Nanomedicine (LOMIN)

6. National Institute of Biomedical Imaging and Bioengineering (NIBIB)

7. National Institutes of Health (NIH)

8. Bethesda, United States

9. Department of Biomedical Engineering

10. School of Pharmaceutical Sciences

11. Laboratory of Cellular Imaging and Macromolecular Biophysics

Abstract

We developed a clinically translatable photothermal theranostic agent based on a heptamethine dye, CySCOOH conjugated HSA, for multimodality imaging and photothermal tumor ablation.

Funder

National Institute of Biomedical Imaging and Bioengineering

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2015/NR/C5NR04428F

Reference36 articles.

1. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology

2. Protein nanoparticles as drug carriers in clinical medicine

3. Protein-Based Nanomedicine Platforms for Drug Delivery